Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages...

View the Online Magazine

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

WHO prequalifies new dengue vaccine

A new vaccine for dengue has received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to be prequalified by...

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Approvals

Zai Lab and Innoviva Specialty Therapeutics secure approval for XACDURO for hospital-acquired and ventilator-associated pneumonia in China

China’s National Medical Products Administration (NMPA) has approved Zai Lab’s New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of hospital-acquired bacterial pneumonia...

FDA approves Amgen’s IMDELLTRA for the treatment of extensive-stage small cell lung cancer

The U.S. Food and Drug Administration (FDA) has approved Amgen's IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer...

Manufacturiung

Finance

Research & Development
Latest

Researchers show new therapeutic avenues in bone repair

Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature...

Nuvalent receives U.S. FDA breakthrough therapy designation for NVL-655

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) to Nuvalent's NVL-655 for the treatment of patients with locally advanced or...

New 3D printing research paves way for personalised medication

A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalised pills...

AC Immune and Takeda sign agreement for active immunotherapy designed to delay Alzheimer’s disease progression

Takeda and AC Immune have announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta...

AbbVie and Gilgamesh Pharmaceuticals to develop next-generation therapies for psychiatric disorders

AbbVie and Gilgamesh Pharmaceuticals have announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise...

Appointments